Faculty, Staff and Student Publications
Language
English
Publication Date
10-15-2024
Journal
Cancer
DOI
10.1002/cncr.35433
PMID
38896064
Abstract
Introduction: NPM1-mutated (NPM1mut) myeloid neoplasms (MNs) with < 20% bone marrow (BM) blasts (NPM1mut MNs< 20) are uncommon, and their classification remains inconsistent.
Methods: The clinicopathologic features of 54 patients with NPM1mut MNs < 20 were evaluated and compared with wild-type NPM1 MNs < 20 and NPM1mut MNs≥20, respectively.
Results: NPM1mut MNs had similar features regardless of blast percentage, except for higher IDH2 (29% vs 7%, p = .023) and FLT3 (70% vs 11%, p < .001) frequency in patients with ≥20% BM blasts. Thirty-three (61%) patients with NPM1mut MNs < 20 received low-intensity chemotherapy (LIC) and 12 (22%) received intensive chemotherapy (IC). Higher complete remission rates (75% vs 27%, p = .006) and median overall survival (mOS) (not reached vs 30.4 months, p = .06) were observed with IC compared to LIC. Young patients (age < 60 years) did not reach mOS either when treated with LIC or IC. Stem cell transplant was associated with increased survival only in patients treated with LIC (HR, 0.24; p = .025). No differences in mOS were observed by BM blast strata (32.2 months, not reached and 46.9 months for < 10%, 10%-19%, and ≥20% blasts, p = .700) regardless of treatment modality (LIC: p = .900; IC: p = .360). Twenty-three patients (43%) with NPM1mut MNs < 20 had marrow blast progression to ≥20%.
Conclusions: Overall, NPM1mut MNs define a unique entity independent of BM blast percentage.
Keywords
Humans, Nucleophosmin, Male, Middle Aged, Nuclear Proteins, Female, Aged, Adult, Mutation, Myeloproliferative Disorders, Bone Marrow, Young Adult, Aged, 80 and over, fms-Like Tyrosine Kinase 3, Prognosis, NPM1 mutation, intensive chemotherapy, myelodysplastic syndromes, myeloid neoplasms, stem cell transplant
Published Open-Access
yes
Recommended Citation
Gener-Ricos, Georgina; Bataller, Alex; Rodriguez-Sevilla, Juan Jose; et al., "NPM1-Mutated Myeloid Neoplasms Are a Unique Entity Not Defined by Bone Marrow Blast Percentage" (2024). Faculty, Staff and Student Publications. 5584.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5584
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons